The cell surface receptor for gibbon ape leukemia virus (Glvr-1) was recently demonstrated to serve normal cellular functions as a sodiumdependent phosphate (NaPi) transporter. This protein belongs to a newly identified phosphate transporter/retrovirus receptor gene family distinct from renal type I and II NaPi transporters. Although inorganic phosphate (Pi) transport is an important function of osteoblasts and of the matrix vesicles produced by these cells in the context of bone matrix calcification, the molecular identity of the NaPi transport system(s) present in this cell type is still unknown. In contrast to Pi uptake mediated by renal NaPi transporters, the activities of both the osteoblastic transport system and Glvr-1 are decreased at alkaline pH, and this observation led us to investigate expression of this transporter in human SaOS-2 osteosarcoma cells.
I
NORGANIC phosphate (Pi) is essential for the formation and mineralization of bone. Pi is indeed not only an integral component of the hydroxyapatite crystal, but is also necessary for the development and the activity of osteogenic cells, which are involved in the synthesis and calcification of the bone extracellular matrix.
Pi uptake in osteoblast-like cells is a saturable, carriermediated process that can be regulated by many osteotropic factors, including PTH, platelet-derived growth factor, and fluoride (1, 2) . Pi enters the cells through a sodium-dependent Pi (NaPi) transport system present in the plasma membrane (1) (2) (3) . A Pi carrier with similar functional properties is also found in the matrix vesicles released by osteogenic cells into the bone extracellular matrix, where accumulation of Pi is thought to play an essential role in the initiation of matrix calcification (1, 2) . Although substantial information is available about the functional characteristics of this transport system, its molecular identity is unknown.
During the last years, several mammalian NaPi transporter families have been described (4 -7) . Two nonhomologous sodium-phosphate cotransport systems, called type I and II NaPi, were identified in the renal cortex of various species (4) . Both types of transporters are almost exclusively expressed in the kidney, where, in particular, type II NaPi plays a major role in the regulation of proximal tubular phosphate transport (4) . More recently, the cell surface receptors for gibbon ape leukemia virus (Glvr-1) and amphotropic murine retrovirus (Ram-1) have been demonstrated to serve normal cellular functions as sodium-dependent phosphate transporters (5-7). These proteins belong to a new type III phosphate transporter/retrovirus receptor gene family and are expressed in a wide variety of tissues (5, 7) . The three types of NaPi differ markedly in tissue distribution, structure, and function (4, 7) . Characteristics of Pi transport in bone-forming cells suggest that involved carriers are distinct from the type I and II renal transporters (3, 4) . Recent studies showed that injection of messenger RNA (mRNA) from rat osteoblast-like cells could induce NaPi transport in Xenopus laevis oocytes. This mRNA did not hybridize to rat renal NaPi-2, suggesting the presence in osteoblast-like cells of a transport system different from that of type II NaPi (8) . A distinctive feature of the different types of NaPi is the influence of pH on their activity. Unlike the activity of renal NaPi transporters, which is increased at alkaline pH, Pi uptake mediated by type III NaPi is decreased when pH increases (4 -7). The osteoblastic Pi transport system exhibits a pH dependence similar to that of the type III NaPi (3), and this similarity prompted us to investigate whether type III family members were expressed in osteoblast-like cells.
Insulin-like growth factor I (IGF-I), which is an important regulator of Pi handling in the kidney, in particular during growth, is also one of the most abundant growth factors present in bone (9 -11). As IGF-I has been demonstrated in various in vitro models to stimulate proliferation, differentiation, and Pi transport in osteogenic cells, we were further interested in the potential effect of IGF-I on our experimental system (10 -13) .
The aims of this study were thus to investigate the expression of the type III NaPi Glvr-1 in human SaOS-2 cells, an osteosarcoma-derived cell line with many osteoblast-like characteristics, and to test whether expression of Glvr-1 and Pi uptake could be influenced by IGF-I in these cells.
Materials and Methods Materials
FCS was obtained from Amimed Produkte-BioConcept (Allschwil, Switzerland), and all other cell culture reagents were purchased from Life Technologies (Basel, Switzerland). Recombinant human IGF-I was provided by Ciba Geigy (Basel, Switzerland) and was dissolved as a concentrated solution in a 0.1-m acetic acid solution containing 0.1 g/100 ml BSA. Actinomycin D and cycloheximide were obtained from Sigma Chemical Co. (St. Louis, MO) and dissolved as concentrated solutions in dimethylsulfoxide (DMSO). The RNeasy total RNA purification kit was obtained from Qiagen (Hilden, Germany). The 18S ribosomal RNA (rRNA) antisense oligonucleotide was obtained from MWG-Biotech (Ebersberg, Germany Autoradiographies were quantitated using the 300A Computing densitometer from Molecular Dynamics (Sunnyvale, CA).
Cell culture
Human osteoblast-like SaOS-2 cells (14) were cultured in DMEMHam's F-12 (1:1) containing 10% FCS, 100 IU/ml penicillin, and 100 g/ml streptomycin. All cultures were maintained at 37 C in a humidified atmosphere of 5% CO 2 -95% air. Subcultures were obtained once a week by removing the cells from the dishes using 0.25% trypsin in a Ca-and Mg-free Earle's salt solution containing 2 mmol/liter EDTA. The cells were plated in 16-mm 24-well tissue culture clusters for Pi and alanine uptake measurements and DNA content determinations or in 162-cm 2 cell culture flasks for RNA extraction. They reached confluence within 3 days, and the assays were performed on days 5-6. For all experiments, confluent SaOS-2 cells were preincubated for 18 h in DMEM-Ham's F-12 medium containing 0.25% FCS before stimulation with IGF-I or its vehicle for the indicated times. In some experiments cells were exposed to 1 or 2 g/ml actinomycin D before or after stimulation with IGF-I. Actinomycin D (1 g/ml) has been previously shown to inhibit transcription in SaOS-2 cells (15) . To inhibit translation, cells were preincubated for 90 min with 5 m cycloheximide, a concentration sufficient to inhibit protein synthesis in SaOS-2 cells (16).
Uptake of Pi or alanine
Transport studies were performed in Earle's Buffered Salt Solution (EBSS) as previously described (17) . Pi transport was initiated by adding 0.3 ml EBSS containing 0.1 g/100 ml BSA, 0.1 g/100 ml d-glucose, and 0.1 mm H 3 4 . IGF-I, actinomycin D, cycloheximide, or their respective vehicles were not added to the uptake solution during the transport determination. After 6 min for Pi or 2 min for alanine, solute uptake was stopped by washing the cell layer three times with ice-cold (4 C) substrate-free EBSS. The cells were then solubilized with 300 l 0.2 n sodium hydroxide, and the radioactivity was counted by a standard liquid scintillation technique. The sodium-independent components of Pi and alanine uptake were determined by replacing NaCl in the uptake solution with choline chloride.
DNA content
DNA content was measured in parallel to Pi and alanine uptake in cells that were stimulated with IGF-I or its vehicle for the indicated times. The cells were detached from the wells by a 10-min incubation at 37 C with 0.1% collagenase and 0.25% trypsin in Ca-and Mg-free Earle's salt solution containing 2 mmol/liter EDTA, and DNA content was measured as described by Burton (18) , using calf thymus DNA as a standard.
Northern blot analysis
After stimulation of SaOS-2 cells with IGF-I or its vehicle for the indicated times, the culture medium was removed, and the cells were stored at Ϫ80 C until total RNA was isolated using the RNeasy kit from Qiagen according to the manufacturer's instructions. Ten micrograms of total RNA were denatured in glyoxal and separated by electrophoresis on a 1.2% agarose gel. RNA was transferred to Hybond N, GeneScreen Plus, Zeta-Probe GT, or Immobilon S membranes by capillary transfer. Membranes were UV cross-linked and stained with methylene blue to control equal sample loading.
The membranes were hybridized to a PCR-amplified fragment (from bp 1208 to bp 1920) of the human Glvr-1 complementary DNA (cDNA; GenBank accession no. L20859) (19) , which was labeled with 50 Ci [␣-
32 P]deoxy-CTP by random priming. This central region of the Glvr-1 cDNA exhibits low homology to the related Glvr-2 (GenBank accession no. L20852) (20) . Prehybridization (30 min) and hybridization (2 h) were performed in Quickhyb buffer (Stratagene), which was supplemented for the hybridization with 100 g/ml salmon sperm DNA. Membranes were washed twice for 15 min each time in 2 ϫ SSC (standard saline citrate)-0.1% SDS at 25 C and for 10 -30 min at 60 C in 0.1 ϫ SSC-0.1% SDS before exposition to Kodak X-Omat AR films (Eastman Kodak, Rochester, NY) for 18 -72 h at Ϫ80 C. To correct for differences in sample loading by assessing the expression of a housekeeping gene, membranes were stripped in 0.1 ϫ SSC-0.1% SDS at 95 C and rehybridized with a BamHI fragment of the human cyclophilin cDNA (21), using hybridization conditions similar to those used for Glvr-1. Alternatively, equal sample loading was confirmed by rehybridizing the membranes to a 5Ј-end-labeled 32-mer oligonucleotide complementary to the human 18S rRNA (5Ј-CCTGTATTGTTATTTTTCGTCACTACCTCCCC-3Ј). Hybridization was carried out at 63 C in Quickhyb buffer supplemented with 100 g/ml salmon sperm DNA. Membranes were washed for 5 min in 2 ϫ SSC-0.5% SDS at 25 C, for 15 min in 2 ϫ SSC-0.1% SDS at 25 C, and for 20 min in 0.1 ϫ SSC-0.5% SDS at 37 C. Signals were quantitated by densitometry.
Statistical analysis
Results are expressed as the mean Ϯ sem. Significance of differences was calculated by two-tailed unpaired Student's t test. A difference between experimental groups was considered significant when p Ͻ 0.05. 
Results

Characteristics of Pi transport stimulation by IGF-I in SaOS-2 cells
The effect of IGF-I on sodium-dependent Pi uptake was investigated in confluent SaOS-2 cells. The initial rate of Pi uptake was significantly increased in cells stimulated for 6 or 24 h with 10 Ϫ7 m IGF-I ( Table 1 ). The Na-independent component of Pi uptake accounted for less than 20% of total Pi uptake in vehicle-treated cells and was not affected by IGF-I. This component was thus neglected in further experiments. Sodium-dependent Pi uptake was preferentially increased compared with sodium-dependent alanine transport, which was not changed after 6-h incubation with 10 Ϫ7 m IGF-I and was only slightly increased after 24 h (Table 1 ). This observation suggests that the change in Pi uptake induced by IGF-I is mediated by a selective cellular mechanism rather than by a general alteration in the Na gradient driving force. In the same experimental conditions, DNA content was not changed in IGF-I-treated cells after 6 h and increased by only 15% after 24 h ( Table 1) .
The stimulation of Pi transport by IGF-I was dose dependent (Fig. 1A) . A significant increase was observed in response to 10 Ϫ11 m IGF-I, and maximal stimulation was achieved at 10 Ϫ8 -10 Ϫ7 m. The effect of IGF-I was time dependent and progressive; it was first detectable after 4 h and reached a maximal value after 18 h (Fig. 1B) . Furthermore, the stimulation of Pi transport by IGF-I appeared to be dependent on RNA and protein synthesis, as it was completely blocked in cells pretreated with either actinomycin D (Fig.  2A) or cycloheximide (Fig. 2B) . Kinetic analysis indicated that the stimulatory effect of IGF-I on Pi uptake was related to an increase in the maximal rate (V max ) of the transport system, without a significant change in the apparent K m (Fig.  3 and Table 2 ).
Time-and dose-dependent stimulation of Glvr-1 mRNA expression by IGF-I in SaOS-2 cells
Northern blotting analysis revealed the presence of a 4-kilobase transcript corresponding to Glvr-1 in SaOS-2 cells. Analysis of time-dependent changes in Glvr-1 mRNA Ϫ7 M IGF-I or its vehicle for the indicated times were analyzed by Northern blotting with a probe for human Glvr-1. A representative experiment is shown. The positions of 28S and 18S rRNAs are indicated on the right. B, The membrane was stripped and rehybridized with a probe for cyclophilin. C, The autoradiographies were quantified by densitometry, and the integrated optical density of the Glvr-1 band, corrected for cyclophilin, is shown for each lane below the blots. expression in response to 10 Ϫ7 m IGF-I revealed a transient stimulation that was detectable after 1 h and maximal after 4 h (Fig. 4) . Glvr-1 mRNA levels then returned to baseline within 18 h. Expression of the housekeeping gene cyclophilin was not significantly affected by IGF-I at any time point (Fig.  4B) .
The induction of Glvr-1 mRNA expression by IGF-I was dose dependent (Fig. 5) and, taking into account the lower sensitivity of Northern blot analysis compared with Pi uptake measurements, was approximately parallel to the dosedependent increase in Pi transport (Fig. 1A ). An increase in Glvr-1 mRNA was indeed detectable from 10 Ϫ10 m IGF-I and progressive up to 10 Ϫ7 m IGF-I. Steady state Glvr-1 mRNA levels in cells exposed to 10 Ϫ7 m IGF-I for 4 h were consistently more than 4-fold higher than those observed in vehicle-treated cells (Figs. 4C and 5C ).
Mechanism of Glvr-1 mRNA induction by IGF-I in SaOS-2 cells
To test whether the observed increase in Glvr-1 mRNA expression was dependent on new RNA synthesis, transcription was inhibited by preincubation of the cells with 1 g/ml actinomycin D for 1 h before the addition of 10 Ϫ7 m IGF-I. suggesting that this response was dependent on transcription (Fig. 6, A and B) .
We also examined whether new protein synthesis was required for the stimulation of Glvr-1 expression by IGF-I, using cycloheximide as a translational inhibitor (Fig. 6, C and  D) . SaOS-2 cells were preincubated with 5 m cycloheximide for 90 min before stimulation with 10 Ϫ7 m IGF-I for 4 h. The inhibition of protein synthesis did not interfere with the induction of Glvr-1 mRNA by IGF-I. This observation suggests that the synthesis of new intermediary gene products is not necessary to enable SaOS-2 cells to increase Glvr-1 mRNA expression in response to IGF-I.
To investigate whether IGF-I affected the stability of Glvr-1 mRNA, SaOS-2 cells were stimulated for 4 h with 10 Ϫ7 m IGF-I before transcription was inhibited with actinomycin D (Fig. 7) . Glvr-1 mRNA levels decreased rapidly after the addition of 1 g/ml actinomycin D (Fig. 7A) . The half-life of the Glvr-1 transcript appeared to be shorter than 1 h, and no difference in Glvr-1 mRNA stability could be detected between IGF-I-and vehicle-treated cells (Fig. 7, C and D) . Together with the results shown in Fig. 6 , A and B, these observations suggest that the increase in Glvr-1 mRNA steady state levels observed in response to IGF-I in SaOS-2 cells mainly reflects a stimulatory effect of IGF-I on the transcription of this gene.
Discussion
Glvr-1 belongs to a recently identified family of type III NaPi transporters that are expressed in a wide variety of tissues, including kidney, liver, lung, striated muscle, heart, and brain (5) . This is to our knowledge the first report on the expression of a type III NaPi transporter in osteoblast-like cells as well as the first description of the molecular identity of a NaPi transporter expressed in bone-forming cells. The size of the Glvr-1 transcript observed in human SaOS-2 cells is similar to that reported for Glvr-1 mRNA in various rat tissues (5) .
IGF-I is one of the most abundant growth factors present in bone and has been shown to stimulate bone growth in vivo as well as proliferation and activity of bone-forming cells in vitro (10 -12) . In this study, IGF-I significantly enhanced Pi transport and Glvr-1 mRNA expression in SaOS-2 cells. The stimulation of Pi transport was selective, and dose and time dependent. The increase in Pi uptake was related to a change in the V max of the transport system and was blocked by transcriptional and translational inhibitors, suggesting that IGF-I may induce the synthesis of new Pi carriers and their insertion into the plasma membrane. IGF-I was previously reported to stimulate Pi transport in two different types of osteogenic cells: rat UMR-106 -01 osteoblast-like cells and chicken growth plate chondrocytes (12, 13) . Pi transport stimulation by IGF-I in chicken growth plate chondrocytes was comparable in terms of selectivity, and dose and time dependency to that observed in SaOS-2 cells (13). In contrast, higher concentrations of IGF-I were required in UMR-106 -01 cells to observe a significant increase in Pi uptake, and the effect was independent of protein synthesis, suggesting a different mechanism of action for IGF-I in UMR-106 -01 compared with SaOS-2 cells (12) .
IGF-I dose dependently increased Glvr-1 expression in SaOS-2 cells. It appeared to act mainly on the transcription of the Glvr-1 gene without affecting the stability of the Glvr-1 mRNA, and the induction of Glvr-1 mRNA by IGF-I did not require the synthesis of intermediate gene products. The increase in Glvr-1 mRNA expression was transient, and its peak preceded by several hours the maximal expression of Pi transport stimulation. The parallel between the induction of Glvr-1 mRNA expression and Pi transport stimulation strongly suggests that Glvr-1 mediates at least part of the stimulatory effect of IGF-I on Pi transport in SaOS-2 cells. Consistently with this hypothesis the delay observed between the peak of Glvr-1 mRNA expression and the maximal increase in Pi uptake might reflect the time required for the translation of the newly transcribed mRNA and for the insertion of the protein into the plasma membrane to form new functional transport sites.
The apparent K m observed for Pi uptake in SaOS-2 cells (450 -500 m) is on the same order of magnitude as those reported for other osteoblast-like cell lines (3, 17) . This apparent K m is higher than those measured for Glvr-1 expressed in oocytes (24 m) or overexpressed in 208F rat embryo fibroblasts or Mus dunni tail fibroblasts (70 and 53 m, respectively) (5, 6). These differences could reflect cell type-specific features, such as cell membrane properties, posttranslational modifications, or expression of distinct regulatory proteins; however, the potential existence in SaOS-2 cells of other Pi transport systems in addition to Glvr-1 has not been investigated to date and thus cannot be excluded.
Several in vitro observations suggested that Pi transport plays an important functional role in osteogenic cells and in their matrix vesicles for the initiation of bone matrix calcification (1, 2, 13) . The identification of a NaPi transporter expressed in bone-forming cells now provides new molecular tools to study the role of Pi transport and its regulation during bone formation, in particular in relation to bone matrix mineralization. We are currently investigating the expression of Glvr-1 mRNA during the development of murine metatarsals by in situ hybridization. Preliminary data suggest that in this model of endochondral bone formation, Glvr-1 is selectively expressed in a subpopulation of early hypertrophic chondrocytes in a region close to the onset of matrix mineralization (our unpublished data). These observations, which are consistent with a potential role for the Glvr-1 phosphate transporter in initial events of matrix calcification, further suggest important functions for type III NaPi transporters in the context of bone formation in vivo.
In conclusion, this study shows for the first time the expression of a type III NaPi transporter in osteoblast-like cells. Our data also indicate that both the expression of this transporter and Pi transport are stimulated by IGF-I in SaOS-2 cells and thus suggest that type III NaPi transporters may be involved in regulated Pi handling in osteogenic cells. The identification of a NaPi transporter exhibiting regulated expression in bone-forming cells, besides providing new tools to investigate the molecular mechanisms of Pi transport regulation, should also lead to a better understanding of the role of Pi in the metabolism, growth, and differentiation of osteogenic cells as well as in initial steps of bone matrix calcification.
